Functional bionanomaterials for cell surface engineering in cancer immunotherapy

APL Bioengineering
|May 13, 2021
PubMed

Insights

Cell surface engineering (CSE) uses functional bionanomaterials to enhance cancer immunotherapy by improving interactions between immune effector cells and tumor cells for better anticancer immunity.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Immunology

Background:

  • The cell surface is critical for immune recognition and privilege in cancer.
  • Cell surface engineering (CSE) offers a promising strategy to enhance cancer immunotherapy.
  • Functional bionanomaterials are increasingly utilized for CSE applications.

Purpose of the Study:

  • To review recent advancements in using functional bionanomaterials for cell surface engineering (CSE) in cancer immunotherapy.
  • To highlight the role of CSE in modulating immune effector cell (IEC) and tumor cell interactions.
  • To discuss the potential of CSE for developing novel cancer immunity paradigms.

Main Methods:

  • Application of functional bionanomaterials for cell surface modification.
  • Techniques include genetic engineering, metabolic labeling, chemical conjugation, and hydrophobic insertion.
  • CSE can be performed ex vivo or in vivo, on immune effector cells or tumor cells.

Main Results:

  • Engineered cell surfaces facilitate enhanced recognition and interaction between IECs and tumor cells.
  • CSE strategies lead to improved anticancer immunity.
  • Development of new paradigms in cancer immunity through surface manipulation.

Conclusions:

  • Functional bionanomaterials are key to advancing cell surface engineering for cancer immunotherapy.
  • CSE holds significant potential for eliciting effective and targeted anticancer immune responses.
  • Further research in bionanomaterial-based CSE can lead to innovative cancer treatment strategies.

Related Concept Videos